beat365Õý°æΨһ¹ÙÍø

¿ÆÑÐЧÀÍ

RESEARCH SERVICES
¿ÆÑÐЧÀÍ
Ñõ»¯Èý¼×°·¼°Ïà¹Ø´úлÎï
Ñõ»¯Èý¼×°·¼°Ïà¹Ø´úлÎï(ͼ1)²úÆ·¼ò½é

Ñõ»¯Èý¼×°·(Trimethylamine N-oxide, TMAO)Êdz¦µÀÑáÑõ¾úÓëÈËÌåÅäºÏÐγɵĴúл²úÆ·¡£³¦µÀ¾úȺ½«Ö±½ÓÒûʳÉãÈë»ò¼ä½ÓÌìÉúµÄµ¨¼î¡¢Ìð²Ë¼î¡¢Èâ¼îÀàת»¯Îª¾ß³ôζÓë»Ó·¢ÐÔµÄÈý¼×°·(Trimethylamine, TMA)¡£Èý¼×°·¿ÉÒÔÖ±½Ó±»³¦µÀÎüÊÕ £¬¾­ÓɸÎÞ²Âö½øÈë¸ÎÔàºó¼´±»¸ÎÔàϸ°ûµÄ»ÆËص¥Ñõ»¯(Flavin Monooxygenase, FMO)Ñõ»¯ÐγÉÑõ»¯Èý¼×°·½øÈëѪҺѭ»·ÖС£

ÏÖÔÚÑõ»¯Èý¼×°·Òѱ»·¢Ã÷¿ÉÒÔ͸¹ýÔö½ø¾ÞÊÉϸ°ûȺ¼¯Ñª¹Ü±Ú¡¢ÒÖÖƵ¨¹Ì´¼½ÓÄÉ·¾¶¡¢ÓëÔöǿѪС°åÄý¼¯»îÐԵȻúת £¬µ¼ÖÂѪ¹ÜÖà×´¶¯ÂöÓ²»¯ÓëѪ¹Ü˨ÈûµÄÐγÉ¡£TMAOºÍÐÄѪ¹Ü¼²²¡Ö®¼äµÄÁªÏµÒѾ­ÔÚ²î±ðÐÐÁÐÖоÙÐÐÁËÑо¿ £¬³ý´ËÖ®Íâ £¬TMAO»¹»á¶ÔÂýÐÔÉö²¡Éö¹¦Ð§²»È«ºÍéæÃüΣº¦¡¢IIÐÍÌÇÄò²¡¡¢ÒȵºËضԿ¹¡¢·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎºÍijЩ°©Ö¢µÄ±¬·¢Éú³¤±¬·¢Ó°Ïì¡£¼ì²âTMAO¼°Ïà¹Ø´úлÎïµÄˮƽÓпÉÄÜΪTMAOÏà¹Ø¼²²¡µÄ¸ÉÔ¤Ìṩһ¶¨µÄÒÀ¾Ý¡£
Ñõ»¯Èý¼×°·(Trimethylamine N-oxide, TMAO)±£´æÓÚÖíÈâ¡¢¼¦µ°¡¢ÓãϺÖÐ £¬¾ßÓÐÒ»ÖÖÌØÊâµÄÏÊζ,¾­Î¢ÉúÎïºÍøÆÊÎö±¬·¢Èý¼×°·(Trimethylamine, TMA) £¬¿É×÷ΪĥÁ·º£ÏʺÍÐóÇݵÈÈâÀàʳÎïÐÂÏʶȵÄÖ¸±ê¡£Ò»Ñùƽ³£ÇéÐÎÏÂ,Ñõ»¯Èý¼×°·/Èý¼×°·±ÈÖµÔ½¸ß £¬Åú×¢ÈâÆ·¸üÐÂÏÊ¡£Ñõ»¯Èý¼×°·»¯Ñ§½á¹¹Óë¼×»ù¹©Ì嵨¼î¡¢Ìð²Ë¼îºÍS-ÏÙÜÕ¼×Áò°±ËáµÈÏàËÆ £¬¶¼¿ÉÔÚÌåÄÚת»¯Îªµ¨¼î £¬µ¨¼îÄܹ»Í¨Ï꾡¾úµÄÍÑ°±»ù×÷ÓÃË®½âÉú²úTMA £¬TMAÊÇÒ»Öָ߻ӷ¢ÐÔ°·Àà £¬¾ßÓÐÐÈζ,Ðá¾õãÐÖµ½ÏµÍ £¬Ò»Ñùƽ³£Ó㡢Ϻ¡¢¼¦µ°¡¢Ñ¼µ°¡¢ÖíÈ⡢ţÈâµÈµÄÐÈζ´ó²¿·ÖȪԴÓÚTMA¡£

Ñõ»¯Èý¼×°·¼°Ïà¹Ø´úлÎï¼ì²âÁбí

Ñõ»¯Èý¼×°·¼°Ïà¹Ø´úлÎï¼ì²âÁбí

1¶Ô1×Éѯ

Ñõ»¯Èý¼×°·¼°Ïà¹Ø´úлÎï(ͼ3)ÊÖÒÕõ辶

Ñõ»¯Èý¼×°·¼°Ïà¹Ø´úлÎïÊÖÒÕõ辶

Ñõ»¯Èý¼×°·¼°Ïà¹Ø´úлÎï(ͼ5)ÊÖÒÕ²ÎÊý

Ñù±¾ÒªÇó
Ö²Îï×éÖ¯£º200 mg/sample
¶¯Îï×éÖ¯Ñù±¾£º200 mg/sample
ѪÇ塢Ѫ½¬£º200 ¦ÌL/sample
ÄòÒº£º200 ¦ÌL/sample
·à±ã¡¢³¦µÀÄÚÈÝÎ200 mg/sample

Öü´æºÍÔËÊä
Òºµª»ò-80¡ãCÉúÑÄ£»×ãÁ¿¸É±ùÔËÊä £¬×èÖ¹Öظ´¶³ÈÚ

¼ì²âƽ̨
Qtrap 6500+, Sciex

ͨÀýÏîÄ¿ÖÜÆÚ
ʵÑé¼ì²â£º35¸ö×ÔÈ»ÈÕ£¨´ÓÊÕµ½¿Í»§Ô¤¸¶¿î²¢ÊÕµ½ÑùÆ·Ö®ÈÕÆð£©
Êý¾ÝÆÊÎö£º5¸ö×ÔÈ»ÈÕ

icon-27.pngÓ¦ÓÃÆ«Ïò
  • ¿ÆÑÐЧÀÍÍøÕ¾icon-11.png
    TMAOÀàÎïÖÊ´úлÑо¿
  • ¿ÆÑÐЧÀÍÍøÕ¾icon-07.png
    TMAOÏà¹Ø¼²²¡µÄÕï¶Ï¼°Õ¹Íû £¬²¡Òò»úÖÆ¡¢ÁÆЧÆÀ¹ÀµÈÑо¿
icon-28°¸ÀýÆÊÎö

΢ÉúÎï´úлÎïÑõ»¯Èý¼×°·Ôö½øÈýÒõÐÔÈéÏÙ°©µÄ¿¹Ö×ÁöÃâÒß

Ñо¿¹¤¾ß£º                ÈýÒõÐÔÈéÏÙ°©»¼Õß

ÆÚ¿¯£º                      Cell Metabolism

Ó°ÏìÒò×Ó£º               31.373

ʱ¼ä£º                      2022Äê

Ñо¿Åä¾°
ÈýÒõÐÔÈéÏÙ°©(Triple Negative Breast Cancer, TNBC)ÊÇÒ»ÖÖÇÖÏ®ÐÔ¼²²¡ £¬Ô¤ºó²î £¬ÃâÒßÖÎÁÆÔÚ»¼ÕßÖÐÈ¡µÃµÄÀÖ³ÉÓÐÏÞ¡£ÈýÒõÐÔÈéÏÙ°©(Triple Negative Breast Cancer, TNBC)µÄËÄÖÖÑÇÐÍÖÐ £¬IMÑÇÐ͵ÄÌصãÊÇÔÚ΢ÇéÐÎÖи»¼¯ÃâÒß¼¤»îϸ°ûºÍÃâÒߴ̼¤Òò×Ó £¬ÌáÐÑTNBCµÄIMÑÇÐÍ»¼Õß¿ÉÄܶÔÃâÒßÖÎÁÆÓиüºÃµÄ·´Ó¦¡£Òò´Ë £¬ÆÈÇÐÐèÒªÕÒµ½µ÷ÀíTNBC΢ÇéÐΡ¢Ôö½ø¿¹Ö×ÁöÃâÒßµÄÒò×Ó¡£

Ñо¿Ð§¹û
±¾Ñо¿¶ÔFUSCCTNBCÐÐÁÐ(n=360)µÄת¼×é¡¢´úл×éºÍ΢ÉúÎï×éÊý¾Ý¾ÙÐÐÁËÖÜÈ«ÆÊÎö £¬·¢Ã÷TMAOͨ¹ýÓÕµ¼Ö×Áöϸ°û½¹Íö £¬´Ó¶øÔöÇ¿TNBCÌåÄÚCD8+ Tϸ°û½éµ¼µÄ¿¹Ö×ÁöÃâÒß £¬Ìá¸ßÃâÒßÖÎÁÆÁÆЧ¡£¸ÃÑо¿ÎªÎ¢ÉúÎïȺ-´úл-ÃâÒßÏ໥×÷ÓÃÌṩÁËеĿ´·¨ £¬²¢Åúע΢ÉúÎï´úлÎï £¬ÈçTMAO»òÆäÇ°Ì嵨¼î £¬¿ÉÄÜ´ú±íÁËÒ»ÖÖеÄÖÎÁÆÕ½ÂÔ £¬ÒÔÔö½øÃâÒßÖÎÁƶÔTNBCµÄÁÆЧ¡£

Ñо¿Ë¼Ð÷

Ñо¿Ë¼Ð÷

Ч¹ûչʾ
TNBC»¼ÕßµÄÖ×Áö×é֯΢ÉúÎï¶à×éѧÆÊÎö¼°·Ç°ÐÏò´úл×éѧÆÊÎöÏÔʾ £¬IMÑÇÐÍÖÐËó¾úĿϾúÊôµÄÕ¼±È¸üΪ¸»ºñ £¬ÇÒÆäÖÐÏÔÖø¸»¼¯Ëó¾úÏà¹Ø´úлÎïTMAO £¬·¢Ã÷Tϸ°ûÏà¹Øͨ·ÔÚ¸ßTMAOÑÇȺÖи»¼¯£¨Í¼1£© £¬ÇÒTMAOÓë΢ÇéÐÎÄÚCD8+ Tϸ°û±ÈÀýºÍIFNG±í´ïÁ¿³ÉÕýÏà¹Ø£¨Í¼2£©¡£ÌåÄÚʵÑéÅú×¢Éϵ÷ÌåÄÚTMAOÏÔÖøÔö½øCD8+ Tϸ°ûºÍM1¾ÞÊÉϸ°ûµÄ½þÈó£¨Í¼3£© £¬ÔöÇ¿CD8+ Tϸ°ûµÄ¹¦Ð§²¢ÓÐÓÃÒÖÖÆÈýÒõÐÔÈéÏÙ°©µÄÉú³¤¡£Í¨¹ý»úÖÆ̽Ë÷·¢Ã÷ £¬TMAOÓÕµ¼ÈéÏÙ°©Ï¸°û±¬·¢ÓÉGSDME½éµ¼µÄ½¹Íö £¬´Ó¶øÔöÌí΢ÇéÐÎÖÐCD8+ Tϸ°ûµÄ½þÈó £¬²¢¼¤»îCD8+ Tϸ°ûÊ©Õ¹¿¹Ö×Áö¹¦Ð§¡£Ñо¿Í¬Ê±·¢Ã÷TMAOͨ¹ý»î»¯PERKÂÑ°×£¨Í¼4£© £¬½øÒ»²½ÇиîGSMDEµÄÉÏÓÎÂÑ°×caspase-3ÓÕµ¼Ö×Áöϸ°û±¬·¢½¹Íö¡£ÁÙ´²ÆÀ¹À·¢Ã÷¸ßѪ½¬TMAOˮƽµÄ»¼Õ߶ÔÃâÒßÖÎÁÆ·´Ó¦ÐÔ¸üºÃ£¨Í¼5£©¡£ÇÒСÊóÌåÄÚʵÑéÅú×¢¸ßѪ½¬TMAOˮƽ¿ÉÒÔÓÐÓÃÒÖÖÆСÊóÖ×ÁöµÄÉú³¤¡£ÎªÁË̽ÌÖÁÙ´²¿É¼°µÄÖÎÁƼƻ® £¬Ñо¿Õßͨ¹ý¸øСÊóιʳTMAOÇ°Ìå´úл²úÆ·µ¨¼îÌá¸ß¿ÉÒÔСÊóÖ×ÁöTMAOˮƽ £¬½µµÍÖ×ÁöÉú³¤ËÙÂÊ £¬Ìá¸ßÃâÒßÖÎÁÆÁÆЧ£¨Í¼6£©¡£ËµÃ÷Ôö²¹µ¨¼îÉãÈë¿ÉÒÔ×÷ΪÌá¸ßÈýÒõÐÔÈéÏÙ°©ÃâÒßÖÎÁÆÁÆЧµÄÁÙ´²Ç±ÔÚÖÎÁÆÕ½ÂÔ¡£

ͼ

ͼ

ͼ

ͼ

ͼ

²Î¿¼ÎÄÏ×
Wang Hai,Rong Xingyu,Zhao Gan et al. The microbial metabolite trimethylamine N-oxide promotes antitumor  immunity in triple-negative breast cancer.[J] .Cell Metabolism, 2022, 34: 581-594.e8.

Ãâ·ÑÉêÇëGC-MS·Ç°Ð±ê´úл×éѧ

΢ÐÅ

ÔÚÏß
×Éѯ

QQ

µã»÷QQ×Éѯ

·µ»Ø
¶¥²¿

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿